SCHEMBL27430100

SCHEMBL27430100

CCOCC1(C)CCCN(C)C1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14019463 0.81 USP2 (0.41) USP2TSHR
SCHEMBL23466099 0.78 SLC22A1 (0.34) USP2
SCHEMBL12464686 0.76 OPRM1 (0.33)
SCHEMBL90746 0.75 PARP1 (0.32)
SCHEMBL14586042 0.75
SCHEMBL22663697 0.75 USP2 (0.32) USP2
SCHEMBL14413879 0.74 USP2 (0.33) USP2
SCHEMBL10305806 0.73 HPGD (0.34) TSHR
SCHEMBL10447437 0.73 HPGD (0.34) TSHR
SCHEMBL10447629 0.73 HPGD (0.34) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024076674-A1 HETEROCYCLIC INHIBITORS OF KRAS G12C MUTANT PROTEINS AND USES THEREOF AMGEN INC. (US) 2024-04-11 WO disclosed